SCHEMBL4673598

SCHEMBL4673598

CN(C=CC(=O)c1ccccc1)C(Cc1ccc(OCCc2cccc3c2[nH]c2ccccc23)cc1)C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PPARG P37231 15/20 0.39
PPARA Q07869 3/20 0.36
BCHE P06276 2/20 0.36
ACHE P22303 2/20 0.36
PPARD Q03181 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4673594 0.87 PPARG (0.40) PPARGPPARABCHEACHE
SCHEMBL1720631 0.79 PPARG (0.63) PPARGPPARA
SCHEMBL1720625 0.79 PPARG (0.63) PPARGPPARA
SCHEMBL29930767 0.75 FFAR1 (0.59) PPARGPPARAPPARD
SCHEMBL1720162 0.75 PPARG (0.57) PPARGPPARA
SCHEMBL1720166 0.75 PPARG (0.57) PPARGPPARA
SCHEMBL29930486 0.74 MCL1 (0.43)
SCHEMBL1719751 0.73 PPARG (0.55) PPARGPPARA
SCHEMBL1719745 0.73 PPARG (0.55) PPARGPPARA
SCHEMBL29930415 0.73 MCL1 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1569904-A4 SUBSTITUTED ARYLALCANOIC ACID DERIVATIVES AS PPAR PAN AGONISTS WITH POTENT ANTIHYPERGLYCEMIC AND ANTIHYPERLIPIDEMIC ACTIVITY SHENZHEN CHIPSCREEN BIOSCIENCE (CN) 2008-04-16 EP disclosed
EP-1569904-A1 SUBSTITUTED ARYLALCANOIC ACID DERIVATIVES AS PPAR PAN AGONISTS WITH POTENT ANTIHYPERGLYCEMIC AND ANTIHYPERLIPIDEMIC ACTIVITY Shenzhen Chipscreen Biosciences Ltd. (CN) 2005-09-07 EP disclosed
WO-2004048333-A1 SUBSTITUTED ARYLALCANOIC ACID DERIVATIVES AS PPAR PAN AGONISTS WITH POTENT ANTIHYPERGLYCEMIC AND ANTIHYPERLIPIDEMIC ACTIVITY SHENZHEN CHIPSCREEN BIOSCIENCES LTD. (US) 2004-06-10 WO disclosed